8-K ·Filed Jul 31, 2026

CDT

CDT Equity Inc.
BEARISH
Impact 8/10
Horizonweeks Processed2mo ago SEC0001493152-26-035682
Killer combo: Material agreement + unregistered equity (likely PIPE/convertible)
Actionable Insight ▼ Bearish

The massive potential dilution from 12.1M pre-funded warrants (18x current shares outstanding) is extremely bearish for CDT common stock. However, the warrants cannot be exercised until shareholder approval is obtained, creating a binary catalyst event. Monitor for proxy filing seeking shareholder approval for the warrant issuance — if approved, expect severe downward pressure as warrants become exercisable. The CEO's participation via Corvus Capital (5.4M warrants) raises governance concerns. The separate 123K share issuance to service providers adds further dilution.

DirectionBearish
Confidencehigh
Horizonweeks
Latest settled — T+20d
CDT ▼ -41.36% at T+20d
SHORT call ✓ call won +41.36% · α vs SPY +42.60% · entry $2.87 → $1.68
Next anchor: T+60d in 23d
Latest observation: T+41 +240.99% FF3 residual α
Entry anchored
Jul 31, 05:14 PM ET
via exchange tick
T+1d
+9.60%
call -9.60% · α -7.80%
$3.14
settled 2mo ago
T+5d
+8.55%
call -8.55% · α -6.52%
$3.11
settled 8w ago
T+20d
-41.36%
call +41.36% · α +42.60%
$1.68
settled 5w ago
T+60d
—
call — · α —
—
in 23d

Price Chart

Loading chart...

Executive Summary

CDT Equity Inc. acquired 270 shares of Sarborg Limited (4.76% stake) in exchange for issuing pre-funded warrants to purchase up to 12,131,770 shares of CDT common stock at $0.0001 per share. The warrants cannot be exercised until shareholder approval is obtained, as issuance would exceed Nasdaq's 19.99% cap. Separately, CDT issued 123,537 shares to four service providers for past services. The massive potential dilution (12.1M warrant shares vs. 663K currently outstanding) is extremely bearish for existing common stockholders, though the warrants are locked until shareholder approval.

Key Financial Metrics

Deal Type
other

Key Facts

  • CDT acquired 270 shares of Sarborg Limited, representing ~4.76% of Sarborg's outstanding common stock.
  • Consideration was pre-funded warrants to purchase up to 12,131,770 shares of CDT common stock at $0.0001 per share.
  • As of July 30, 2026, CDT had only 663,179 shares of common stock outstanding.
  • Warrant exercise is blocked until shareholder approval is obtained, as issuance would exceed Nasdaq's 19.99% cap.
  • CEO Andrew Regan's wholly-owned company Corvus Capital received warrants for 5,436,830 shares in the same transaction.
  • Separately, CDT issued 123,537 shares of common stock to four service providers for past services.
  • Company agreed to file a resale registration statement for the warrant shares within 60 days of closing.

Financial Impact

Potential dilution of up to 12,131,770 shares (18.3x current outstanding of 663,179 shares) via pre-funded warrants at $0.0001 exercise price. Plus 123,537 shares already issued to service providers (18.6% dilution).

dilutionshare countmarket cap

Risk Factors

  • Massive dilution risk: 12.1M potential shares vs. 663K outstanding (18.3x) if warrants become exercisable.
  • Shareholder approval vote creates binary risk — approval would unlock severe dilution.
  • CEO Andrew Regan's insider participation (5.4M warrants via Corvus Capital) raises conflict-of-interest concerns.
  • Company has only $2M market cap — warrant exercise at $0.0001 would be nearly free for holders, creating extreme selling pressure.
  • Sarborg stake value is opaque — no financials disclosed for Sarborg or the deal's fairness.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-035682
Exhibit: ex4-1.htm0001493152-26-035682
Document: form8-k.htm0001493152-26-035682
Document: 0001493152-26-035682-index-headers.html0001493152-26-035682
Document: 0001493152-26-035682-index.html0001493152-26-035682
Document: 0001493152-26-035682.txt0001493152-26-035682
8 reports for CDT
Performance horizon
100% Hit rate 5 of 5 directional calls best @ T+20▲ +96.23%Sep 1, 2026
Filters
Rows
Reports for CDT — sortable, filterable
TypeNow
Sep 1, 2026
4w ago
8-K
BEARISH ★ 6/10
$37.00 $1.40▲ +96.23%▲ +97.41%$1.25 (+96.62%)
Jul 31, 2026
9w ago
8-K
BEARISH ★ 8/10
$2.87 $1.68▲ +41.36%▲ +42.60%$1.25 (+56.37%)
Jul 16, 2026
11w ago
8-K
BEARISH ★ 5/10
$0.3550 $3.15▼ −785.92%▼ −782.30%$1.25 (−252.11%)
Jun 29, 2026
13w ago
8-K
BEARISH ★ 7/10
$0.5600 $2.85▼ −408.04%▼ −409.06%$1.25 (−123.21%)
Jun 16, 2026
15w ago
8-K
BEARISH ★ 7/10
$0.6930 $0.3550▲ +48.77%▲ +50.09%$1.25 (−80.38%)
May 6, 2026
21w ago
Press Release
NEUTRAL ★ 4/10
$2.26 $0.8050▼ −64.38%▼ −67.16%$1.25 (−44.69%)
Mar 4, 2026
30w ago
Press Release
MIXED ★ 6/10
$17.70 $5.10▼ −71.19%▼ −66.77%$1.25 (−92.94%)
Feb 24, 2026
31w ago
8-K
BULLISH ★ 7/10
$17.25 $10.88▼ −36.96%▼ −31.72%$1.25 (−92.75%)
Showing 8 of 8

US Market Status

Market Closed — Opens Mon (37h 29m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access